Aspreva Raises Forecast
Shares of Aspreva Pharmaceuticals Corp. (ASPV) leaped $4.41 to $27.95 after the company raised its first quarter revenue forecast.
posted by FC Market News at 2:02 PM
Thursday, April 13, 2006
Previous Posts
- Market Share Concerns Weigh Down AMD
- Universal Technical Warns Of Shortfall
- SanDisk Added To S&P 500
- Lam Research's Earnings Impress
- Pixelplus Slashes Outlook
- Ceradyne Forecast Exceeds Expectations
- Datalink Swings To Profit
- Emulex Upgraded
- Danaher To Acquire Sybron
- Avid Technology Warns Of Earnings Shortfall
0 Comments:
Post a Comment
<< Home